logo
IKE Tech Files First-Ever PMTA for Standalone Interoperable Blockchain-based Age-Gating System at Point of Use - Marking a New Chapter in Youth Vaping Prevention

IKE Tech Files First-Ever PMTA for Standalone Interoperable Blockchain-based Age-Gating System at Point of Use - Marking a New Chapter in Youth Vaping Prevention

LOS ANGELES, May 1, 2025 /PRNewswire/ -- IKE Tech LLC('IKE Tech'), a leading innovator in the intersection of Internet of Things (IoT), identity verification (IDV) and tokenization technology, announced today that it has filed a component Premarket Tobacco Product Application (PMTA) and Tobacco Product Master File (TPMF) with the US Food and Drug Administration (FDA) for its blockchain-based Bluetooth Low Energy (BLE) System-on-a-Chip with the smartphone-enabled identity and age-verification IKE Mobile Application.
This marks the first ever complete PMTA submission for a standalone, scalable age-gating component that provides real-time continuous age verification at the point-of-use for electronic nicotine delivery systems (ENDS). The IKE System is designed for universal integration across all ENDS devices, utilizing unique blockchain-based tokenization technology to further ensure user privacy and security.
According to a multi-center Human Factors Validation Study submitted as part of the PMTA, the IKE system proved to be 100% effective in preventing device activation for anyone under the age of 21. The company has formally requested expedited review of its application, emphasizing the system's potential to enhance public health.
'This is a major milestone for IKE Tech and the ENDS category', commented John Patterson, President of IKE Tech. 'We're not just building technology. We're paving a new regulatory framework that gives the FDA and manufacturers powerful tools to safeguard public health and ensure adult-only access to vaping products. With proven, scalable age-gating technology built into ENDS devices, the sector now has a real opportunity to eliminate underage vaping for good'.
One chip, every device: unlocking new era of vaping
IKE Tech adopted a rigorous software development lifecycle, following consultation with the FDA. The IKE platform offers a seamless identity and age verification experience via a single, user-friendly mobile app available on iOS and Android. By leveraging blockchain technology, it securely validates user's identity and age through integrated identity verification (IDV) partners, anchoring credentials to a tokenization system without storing sensitive data on user's device, nor on IKE's system, to ensure complete user privacy and security.
Unlike existing solutions that allow permanent access after a single verification, IKE's system requires continuous verification to maintain device access. Human Factors Validation study showed 91% of users (aged 18 – 67) rated the app as 'Extremely Easy' or 'Very Easy' to use - with a user error rate of less than 0.8% - proving its appeal to the wider market.
'This is a pivotal moment from a regulatory perspective,' said Kevin Burd, CEO of Chemular. By embedding robust age verification at the point of use, the IKE technology enables manufacturers and regulators to confidently allow access to a broader range of products for verified adults. This approach opens the doors for responsible flavor pathways, empowering adult consumers with more choice, while maintaining the highest levels of youth protection.'
Building Smarter and Better ENDS
IKE Tech is dedicated to building a better, more secure future for all. To meet the evolving needs of manufacturers, the company is planning to continue integrating advanced features like counterfeit protection, geofencing, targeted messaging, and real-time data access to its systems.
These innovations are designed to address underage vaping and combat the illicit market, ensuring that only products that FDA has determined are Appropriate for the Protection of Public Health (APPH) are available to adult users.
To learn more about IKE Tech, visit www.iketech.com.
Notes to Editors:
Human Factors Study Design and Key Results
Conducted with 102 participants (51% male, 49% female, aged 18–67 across race/ethnic demographics), the study simulated real-world use of the IKE system. Participants downloaded the app, verified their age, paired with a test device and interacted with BLE-based access controls including biometric reactivation.
Key performance highlights:
Devices could only be reactivated with biometric authentication. Demographic data (age, race/ethnicity, gender) was accurately verified in all cases. The results confirm the IKE System's ability to reduce user error, prevent underage access, and provide a user-friendly experience for adults.
About IKE Tech
IKE Tech LLC ('IKE Tech') is pioneering real-time age and identity verification at the point of use, helping to safeguard access to age-restricted products.
A leading innovator at the intersection of Internet of Things (IoT), identity verification (IDV), and tokenization technology, IKE Tech has developed an industry-first, scalable age-gating component that provides continuous, real-time verification for electronic nicotine delivery systems (ENDS) and other restricted consumer products.
IKE Tech's interoperable Bluetooth Low Energy (BLE) System-on-a-Chip, powered by a user-friendly mobile app available on iOS and Android, integrates seamlessly into ENDS devices, giving manufacturers and regulators a flexible, future-proofed solution to combat underage vaping and illicit markets. By setting the new standard for responsible, adult-only access, IKE Tech is helping eliminate youth vaping for good.
View original content: https://www.prnewswire.com/news-releases/ike-tech-files-first-ever-pmta-for-standalone-interoperable-blockchain-based-age-gating-system-at-point-of-use---marking-a-new-chapter-in-youth-vaping-prevention-302443438.html
SOURCE IKE Tech LLC

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Needham sees FDA's positive CP ruling as best-case outcome for Phathom
Needham sees FDA's positive CP ruling as best-case outcome for Phathom

Business Insider

timean hour ago

  • Business Insider

Needham sees FDA's positive CP ruling as best-case outcome for Phathom

Needham notes that Phathom Pharmaceuticals (PHAT) is trading up 95%-plus this afternoon, following the company's announcement that the food and drug administration has approved the company's Citizen's Petition regarding Voquezna tablets. FDA has also communicated its intention to correct the Orange Book listing to reflect the full 10-year NCE exclusivity. This extends Voquezna's market exclusivity through 5/3/2032. Needham notes the CP/exclusivity issue had been a massive overhang on the stock since November 2024, but it views the news as clearly a best-case scenario and a significant clearing event for the stock. The firm believes Phathom Pharmaceuticals' shares now have a new support level, and thinks shares will move higher in the coming weeks as investors digest the news and take a fresh look at the story, which Needham believes is quite compelling given the strong Voquezna launch and TRx trends. The firm has a Buy rating on the shares with a price target of $28. Confident Investing Starts Here:

Mind Vault Announces Launch of Cognitive Support Supplement for Adults 45 and Older
Mind Vault Announces Launch of Cognitive Support Supplement for Adults 45 and Older

Yahoo

timean hour ago

  • Yahoo

Mind Vault Announces Launch of Cognitive Support Supplement for Adults 45 and Older

Formulated to Support Mental Clarity and Brain Health in Aging Populations Cleveland, June 06, 2025 (GLOBE NEWSWIRE) -- Mind Vault, a cognitive support supplement formulated for adults aged 45 and older, has officially launched and is now available through the company's website. According to the company, the product is designed to support mental clarity and cognitive performance as part of a healthy aging routine. Mind Vault contains a blend of ingredients including Niacin (Vitamin B3), Vitamin B6, GABA, L-Tyrosine, Caffeine, Bacopa Monnieri, Phosphatidylserine, Alpha GPC, L-Theanine, and Huperzine. The formula is manufactured in the United States in an FDA-registered facility and aims to promote general cognitive support. The supplement is available in various supply options through the official website, allowing consumers to choose based on their individual preferences. Mind Vault is available for purchase exclusively through where users can find additional product information and place orders. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consumers are advised to consult with their healthcare provider before use. About Mind Vault Mind Vault is a wellness brand focused on developing accessible cognitive support products for adults experiencing age-related changes in focus, clarity, and memory. The company formulates its supplements in the United States using quality-tested ingredients and manufactures in FDA-registered facilities. With a commitment to transparency and simplicity, Mind Vault offers consumers straightforward access to information and purchasing through its official website at Media Contact: Email: support@ Phone: (302) 200-3480 Website: CONTACT: Email: support@ Phone: (302) 200-3480 Website: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Mind Vault Announces Launch of Cognitive Support Supplement for Adults 45 and Older
Mind Vault Announces Launch of Cognitive Support Supplement for Adults 45 and Older

Yahoo

timean hour ago

  • Yahoo

Mind Vault Announces Launch of Cognitive Support Supplement for Adults 45 and Older

Formulated to Support Mental Clarity and Brain Health in Aging Populations Cleveland, June 06, 2025 (GLOBE NEWSWIRE) -- Mind Vault, a cognitive support supplement formulated for adults aged 45 and older, has officially launched and is now available through the company's website. According to the company, the product is designed to support mental clarity and cognitive performance as part of a healthy aging routine. Mind Vault contains a blend of ingredients including Niacin (Vitamin B3), Vitamin B6, GABA, L-Tyrosine, Caffeine, Bacopa Monnieri, Phosphatidylserine, Alpha GPC, L-Theanine, and Huperzine. The formula is manufactured in the United States in an FDA-registered facility and aims to promote general cognitive support. The supplement is available in various supply options through the official website, allowing consumers to choose based on their individual preferences. Mind Vault is available for purchase exclusively through where users can find additional product information and place orders. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consumers are advised to consult with their healthcare provider before use. About Mind Vault Mind Vault is a wellness brand focused on developing accessible cognitive support products for adults experiencing age-related changes in focus, clarity, and memory. The company formulates its supplements in the United States using quality-tested ingredients and manufactures in FDA-registered facilities. With a commitment to transparency and simplicity, Mind Vault offers consumers straightforward access to information and purchasing through its official website at Media Contact: Email: support@ Phone: (302) 200-3480 Website: CONTACT: Email: support@ Phone: (302) 200-3480 Website: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store